4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-050305
Chief Financial Officer bought 2,000 shares at $2.64 ($5,285)
From the SEC's structured data for this filing
Trades in this filing
SKIBSTED RUSSELL · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-23 | Purchase : show line 1 in the form | +2,000 | $2.64 | $5,285 | 2,000 | D |
| Open-market purchases · 2,000 sh · avg $2.64 · $5,285 | ||||||
Loading xslF345X03/doc4.xml…